TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

被引：481

作者：

Feldmann, M ^{[1
]}

Maini, RN ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England

来源：

NATURE MEDICINE | 2003年 / 9卷 / 10期

关键词：

D O I：

10.1038/nm939

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1245 / 1250

页数：6

共 35 条

[1] INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].

AREND, WP ;

DAYER, JM .

ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160

[2]

*ATTRACT STUD GROU, IN PRESS ARTHR RHEUM

[3]

BOTTAZZO GF, 1983, LANCET, V2, P1115

[4]

BRENNAN FM, 1989, LANCET, V2, P244

[5]

BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449

[6]

Charles P, 1999, J IMMUNOL, V163, P1521

[7] LOCALIZATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN SYNOVIAL TISSUES AND AT THE CARTILAGE PANNUS JUNCTION IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

CHU, CQ ;

FIELD, M ;

FELDMANN, M ;

MAINI, RN .

ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1125-1132

[8] Adverse reactions to TNF-α inhibitors in rheumatoid arthritis [J].

Day, R .

LANCET, 2002, 359 (9306) :540-541

[9] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

KALDEN, JR ;

ANTONI, C ;

SMOLEN, JS ;

LEEB, B ;

BREEDVELD, FC ;

MACFARLANE, JD ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1105-1110

[10]

ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362

← 1 2 3 4 →